JM Gatell
- Infectious Diseases top 10%
- Epidemiology
- Virology top 5%
- Emergency Medicine top 5%
- Immunology
- Co-authors
- Estebán MartínezFelipe GarcíaAna MilinkovicGlòria GarrabouF CardellachTomàs PumarolaSònia LópezEnric Pedrol
- Topics
- HIV/AIDS drug development and treatment (10 papers)HIV Research and Treatment (9 papers)HIV-related health complications and treatments (4 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
JM Gatell
15 papers receiving 394 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 231
- Epidemiology 177
- Virology 166
- Emergency Medicine 138
- Immunology 33
Countries citing papers authored by JM Gatell
This map shows the geographic impact of JM Gatell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JM Gatell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JM Gatell more than expected).
Fields of papers citing papers by JM Gatell
This network shows the impact of papers produced by JM Gatell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JM Gatell. The network helps show where JM Gatell may publish in the future.
Co-authorship network of co-authors of JM Gatell
This figure shows the co-authorship network connecting the top 25 collaborators of JM Gatell. A scholar is included among the top collaborators of JM Gatell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JM Gatell. JM Gatell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Fe de errores: Polifarmacia e interacciones farmacológicas potenciales en una población envejecida con infección por el VIH | 1 |
| 2 | 24 | |
| 3 | 12 | |
| 4 | 16 | |
| 5 | 26 | |
| 6 | 35 | |
| 7 | 6 | |
| 8 | 41 | |
| 9 | 1 | |
| 10 | 24 | |
| 11 | Efficacy and Safety of atazanavir (ATV) Based HAART in patients switched from a stable boosted/unboosted protease-inhibitor (PI) treatment. The SWAN study | 3 |
| 12 | Efficacy of atazanavir (ATV) based HAART in patients switched from a stable PI or boosted PI (PI/r) treatment. Planned week 24 analysis of a phase IIIb 48 week multicenter, open-label, randomized, prospective trial. The SWAN study | 2 |
| 13 | 122 | |
| 14 | 95 | |
| 15 | Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. | 2 |
About JM Gatell
JM Gatell is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 15 papers that have together received 410 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and HIV-related health complications and treatments (4 papers). The work is most often cited by research in Virology (166 citations), Emergency Medicine (138 citations) and Infectious Diseases (231 citations). JM Gatell has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Estebán Martínez, Felipe García, Ana Milinkovic, Glòria Garrabou, F Cardellach, Tomàs Pumarola, Sònia López, Enric Pedrol, Óscar Miró and Elisabet Deig. Their work appears in journals such as Clinical Infectious Diseases, Journal of Virology and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.